Fortress Biotech Inc. Revenue 2013–2025
Fortress Biotech Inc. annual/quarterly revenue history and growth rate from 2013 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Fortress Biotech Inc. revenue for the quarter ending March 31, 2026 was 16.0 M, a 22.06% increase year-over-year.
- Fortress Biotech Inc. revenue for the twelve months ending March 31, 2026 was 63.2 M, a 18.22% decrease year-over-year.
- Fortress Biotech Inc. annual revenue for 2025 was 63.3 M, a 9.69% increase from 2024.
- Fortress Biotech Inc. annual revenue for 2024 was 57.7 M, a 31.76% decrease from 2023.
- Fortress Biotech Inc. annual revenue for 2023 was 84.5 M, a 11.58% increase from 2022.
- Fortress Biotech Inc. annual revenue for 2022 was 75.7 M.
Fortress Biotech Inc. (FBIO) — Frequently Asked Questions
Fortress Biotech Inc. (FBIO) is a publicly traded US company. It has a market capitalization of $77M. In fiscal 2025 it reported revenue of $63M and net income of $7M. Explore FBIO's stock price, financial statements, earnings history, margins and key ratios below.
What is Fortress Biotech Inc.'s market cap?
Fortress Biotech Inc. (FBIO) has a market capitalization of $77M.
What is the FBIO stock price?
FBIO trades at $2.77 (-5.46% on the day).
How much revenue does Fortress Biotech Inc. make?
Fortress Biotech Inc. reported revenue of $63M in fiscal 2025.
Is FBIO profitable?
In fiscal 2025, Fortress Biotech Inc. reported net income of $7M.